Capitalizator.

Capitalize Yourself: Right Data. Real Growth.

Company Analysis

VERO Insider Trading

Venus Concept Inc. | Surgical & Medical Instruments & Apparatus

Comprehensive Trading Performance Summary

The investment history of corporate insiders at Venus Concept Inc. provides a unique lens into the internal conviction of the company's leadership. By analyzing SEC Form 4 filings, investors can track how directors and officers are allocating their own capital. High-conviction buying often signals that management believes the current market price significantly undervalues future growth prospects, while strategic selling might occur for personal liquidity or portfolio diversification. Monitoring these shifts in ownership is essential for understanding the alignment between management and shareholders in the Surgical & Medical Instruments & Apparatus sector.

Transactions on Chart

Open Full Chart
Filing Date Trade Date Reporting Person Relationship Type Price Qty Total, $ Owned After Change, %
2026-03-31 01:16 2026-03-26 Madryn Asset Management, LP 10% owner BUY $0.04 37,537,187 $1,501,487 37,547,373 +368,517.4%
2024-12-05 01:43 2024-12-03 Natale Anthony Director SELL $0.31 42,768 $13,194 0 -100.0%
2024-10-07 22:22 2024-10-03 Masters Michael Willingham 10% owner SELL $0.53 162,896 $85,553 209,803 -43.7%
2024-10-03 02:54 2024-09-30 Masters Michael Willingham 10% owner SELL $0.59 306,135 $179,640 270,075 -53.1%
2024-06-12 23:06 2024-06-07 Masters Michael Willingham 10% owner SELL $1.20 489,948 $589,848 383,345 -56.1%
2022-12-01 00:34 2022-11-28 Natale Anthony Director SELL $0.25 102,859 $26,178 641,507 -13.8%
2022-11-25 22:36 2022-11-22 Natale Anthony Director SELL $0.28 154,284 $42,829 744,366 -17.2%
2022-11-23 01:16 2022-11-21 PORTARO ROSS Officer - President Global Sales BUY $0.22 60,000 $13,200 120,000 +100.0%
2022-11-23 01:07 2022-11-18 HOLLMIG STANLEY TYLER Director BUY $0.20 250,000 $50,000 290,000 +625.0%
2022-11-23 01:05 2022-11-18 Varghese Hemanth Jacob Officer - President/Chief Bus. Officer BUY $0.20 250,000 $50,000 250,000 +100.0%
2022-11-23 01:03 2022-11-18 DE SILVA RAJIV Officer - Officer BUY $0.20 1,250,000 $250,000 1,250,000 +100.0%
2022-09-20 00:00 2022-09-16 Della Penna Domenic Officer - Chief Financial Officer BUY $0.59 60,000 $35,400 126,663 +90.0%
2022-09-13 23:24 2022-09-12 Georgiadis Anna Officer - VP, Global HR BUY $0.71 12,782 $9,083 12,782 +100.0%
2022-09-01 02:03 2022-08-30 Serafino Domenic Director, Officer - Chief Executive Officer BUY $0.33 75,000 $25,020 1,008,758 +8.0%
2022-05-26 23:43 2022-05-24 HOLLMIG STANLEY TYLER Director BUY $0.64 40,000 $25,720 40,000 +100.0%
2022-05-23 23:32 2022-05-20 Serafino Domenic Director, Officer - Chief Executive Officer BUY $0.75 65,000 $48,750 933,758 +7.5%
2022-05-18 01:15 2022-05-17 PORTARO ROSS Officer - President Global Sales BUY $0.85 10,000 $8,500 60,000 +20.0%
2021-12-21 03:11 2021-12-16 PORTARO ROSS Officer - President Global Sales BUY $1.35 20,000 $27,000 50,000 +66.7%
2021-12-18 00:17 2021-12-15 Sullivan Keith J Director BUY $1.25 80,000 $100,000 80,000 +100.0%
2021-12-18 00:15 2021-12-15 Kong Garheng Director, 10% owner BUY $1.25 1,600,000 $2,000,000 6,795,621 +30.8%
2021-12-18 05:45 2021-12-15 EW Healthcare Partners, L.P. 10% owner BUY $1.25 3,920,000 $4,900,000 16,337,856 +31.6%
2021-12-18 01:28 2021-12-15 HealthQuest Partners II, L.P. 10% owner BUY $1.25 1,600,000 $2,000,000 6,795,621 +30.8%
2021-12-18 05:31 2021-12-15 BARRY RICHARD SCOTT Director, 10% owner BUY $1.25 3,920,000 $4,900,000 16,337,856 +31.6%
2021-12-07 02:07 2021-12-03 PORTARO ROSS Officer - President Global Sales BUY $1.35 30,000 $40,500 30,000 +100.0%
2021-12-02 01:29 2021-12-01 Serafino Domenic Director, Officer - Chief Executive Officer BUY $1.32 37,500 $49,583 868,758 +4.5%
2021-11-19 22:40 2021-11-19 Serafino Domenic Director, Officer - Chief Executive Officer BUY $1.48 17,000 $25,111 831,258 +2.1%
2021-11-18 23:44 2021-11-17 Serafino Domenic Director, Officer - Chief Executive Officer BUY $1.60 15,500 $24,812 814,258 +1.9%
2021-08-21 02:19 2021-08-18 Iger Yoni Officer - VP, RA/QA/Clinical Affairs BUY $1.94 5,181 $10,051 5,181 +100.0%
2021-07-13 23:58 2021-07-12 SEDCO Capital Cayman Ltd 10% owner SELL $3.25 50,000 $162,565 922,456 -5.1%
2021-07-13 03:35 2021-07-09 SEDCO Capital Cayman Ltd 10% owner SELL $3.25 57,933 $188,317 972,456 -5.6%
2021-07-12 17:05 2021-07-08 SEDCO Capital Cayman Ltd 10% owner SELL $3.20 100,000 $320,270 1,030,389 -8.8%
2021-07-07 02:35 2021-07-01 SEDCO Capital Cayman Ltd 10% owner SELL $3.20 46,298 $148,154 1,130,389 -3.9%
2021-07-01 00:20 2021-06-28 SEDCO Capital Cayman Ltd 10% owner SELL $3.20 16,646 $53,267 1,176,687 -1.4%
2021-06-17 03:38 2021-06-15 Della Penna Domenic Officer - Chief Financial Officer BUY $2.41 40,000 $96,216 66,663 +150.0%
2021-06-16 01:18 2021-06-14 Serafino Domenic Director, Officer - Chief Executive Officer BUY $2.46 40,000 $98,244 798,758 +5.3%
2021-06-04 00:01 2021-06-01 Zaring Chad A Officer - CCO BUY $2.09 40,000 $83,600 80,000 +100.0%
2020-08-26 00:36 2020-08-21 Zaring Chad A Officer - Chief Commercial Officer BUY $2.72 40,000 $108,968 40,000 +100.0%
2019-12-11 00:22 2019-12-06 Sullivan Keith J Director SELL $2.91 7,284 $21,186 44,133 -14.2%
2019-12-06 02:18 2019-12-03 Sullivan Keith J Director SELL $3.26 5,916 $19,264 51,417 -10.3%
SHOW ENTRIES

How to Interpret $VERO Trades

Not every insider transaction in Venus Concept Inc. is a signal for immediate action. Professional investors look for "cluster buying"—when multiple executives simultaneously purchase $VERO shares on the open market. It is crucial to distinguish between scheduled sales (under Rule 10b5-1) and voluntary increases in ownership, which demonstrate management’s true conviction that the stock is undervalued.

Data Source & Accuracy for VERO

Insider activity data for Venus Concept Inc. is streamed in real-time directly from the SEC EDGAR system. We analyze raw Form 4 filings, filtering out technical adjustments and complex derivative transactions. This provides a transparent view of how ownership structure is evolving in $VERO, allowing you to follow the capital of those with the most intimate knowledge of the company.

UNDERSTANDING THE DATA

FILING DATE: The date and time when the transaction was reported to the SEC. This is when the public first receives the information.

TRADE DATE: The actual day the insider executed the purchase or sale in the market.

INDUSTRY: The specific market sector the company operates in. Useful for identifying broader institutional capital flows across sectors.

OWNED AFTER: The total number of shares held by the insider following the transaction. This highlights the insider's remaining conviction in the company.

CHANGE %: The percentage increase or decrease of the insider's total position. Large percentage changes often carry more weight than the dollar amount alone.

TRADE TYPES DEFINITIONS

BUY: An open market purchase. Typically indicates an insider's belief that the stock is undervalued or poised for growth.

SELL: An open market sale. While often used for diversification or liquidity, large or unexpected sales can be a warning signal.

OPT+S (OPTION EXERCISE & SALE): This occurs when an insider exercises their stock options and sells them immediately. Often part of a structured compensation plan.